Fulgent Genetics, Inc. (FLGT)
Chart Events
Performance Outlook
| Previous Close | 57.65 |
| Open | 57.36 |
| Bid | 56.55 x 800 |
| Ask | 56.68 x 800 |
| Day's Range | 56.00 - 58.57 |
| 52 Week Range | 47.34 - 112.00 |
| Volume | |
| Avg. Volume | 368,768 |
| Market Cap | 1.726B |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | 3.79 |
| EPS (TTM) | 15.03 |
| Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 91.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for FLGT
Related Research
- Fulgent Genetics, Inc.FLGT: Raising target price to $57.00FULGENT GENETICS INC has an Investment Rating of HOLD; a target price of $57.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.RatingFair ValueEconomic Moat7 days agoArgus Research
- PR Newswire
The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test
Helio Genomics ("Helio"), and its commercial partner, Fulgent Genetics (NASDAQ: FLGT) ("Fulgent") announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses code for HelioLiver™, enabling a reimbursement pathway for potential increased access and broader adoption of innovative surveillance tests for liver cancer in the U.S. The code will become effective on October 1, 2022.
- Zacks
Fulgent Genetics, Inc. (FLGT) Dips More Than Broader Markets: What You Should Know
Fulgent Genetics, Inc. (FLGT) closed the most recent trading day at $54.65, moving -0.35% from the previous trading session.
- Zacks
Fulgent Genetics, Inc. (FLGT) Stock Sinks As Market Gains: What You Should Know
Fulgent Genetics, Inc. (FLGT) closed the most recent trading day at $49.73, moving -0.4% from the previous trading session.
